Others may still feel hungry after THC
Glucagon-like peptide-1 (GLP-1) receptor agonists, a new class of drugs sold under names such as Ozempic, Wegovy, and Zepbound, are soaring in popularity for their ability to achieve and sustain substantial weight loss and improve cardiometabolic health
You then have the hurdle of keeping that weight off, which is often the more difficult part
Well talk about semi blue tide and tepirazide, which are the FDA approved substances that are available although tepirazide is not FDA approved for weight loss at the moment, but its coming
Retatrutide shows higher discontinuation rates
Our landmark trial, SELECT, showed that Wegovy is associated with a significant 20% risk reduction of cardiovascular events, backed up with even greater risk reductions in the real-world studies SCORE and STEER